Efficacy and safety of the novel 1L PEG and ascorbate bowel preparation NER1006 versus standard 2L PEG with ascorbate in overnight or morning split-dosing administration: Results from the phase 3 study MORA

Mapping Intimacies ◽

10.26226/morressier.57c5383bd462b80296c9c377 ◽

2016 ◽

Author(s):

Raf Bisschops

Keyword(s):

Bowel Preparation ◽

The Novel ◽

Efficacy And Safety ◽

Phase 3 ◽

Download Full-text

Efficacy and safety of the novel 1L PEG and ascorbate bowel preparation NER1006 versus sodium picosulfate + magnesium citrate in day before split-dosing administration: Results from the phase 3 study DAYB

10.26226/morressier.57c53840d462b80296c9c40d ◽

2016 ◽

Author(s):

Stefan Schreiber

Keyword(s):

Bowel Preparation ◽

The Novel ◽

Efficacy And Safety ◽

Magnesium Citrate ◽

Phase 3 ◽

Sodium Picosulfate ◽

Download Full-text

Tu2084 Efficacy and Safety of the Novel 1L PEG and Ascorbate Bowel Preparation NER1006 Versus Standard 2L PEG With Ascorbate in Overnight or Morning Split-Dosing Administration: Results from the Phase 3 Study MORA

Gastroenterology ◽

10.1016/s0016-5085(16)34289-5 ◽

2016 ◽

Vol 150 (4) ◽

pp. S1269-S1270 ◽

Author(s):

Raf Bisschops ◽

Jonathan Manning ◽

Lucy Clayton ◽

Richard Ng Kwet Shing ◽

Marco A. Alvarez-Gonzalez

Keyword(s):

Bowel Preparation ◽

The Novel ◽

Efficacy And Safety ◽

Phase 3 ◽

Download Full-text

P037 Efficacy and Safety of 1-L NER1006 Bowel Preparation in Patients with Inflammatory Bowel Disease: Analysis of 2 Phase 3 Studies

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000722944.00010.ea ◽

2020 ◽

Vol 115 (1) ◽

pp. S10-S10

Author(s):

Poppers David ◽

Oneto Caterina ◽

Allen Christopher ◽

Albers C. Gregory

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Preparation ◽

Bowel Disease ◽

Efficacy And Safety ◽

Phase 3 ◽

Inflammatory Bowel ◽

Disease Analysis

Download Full-text

Achieving Successful Bowel Preparation (BBPS Score 2-3 per Segment) With Evening/Morning or Morning-Only Split-Dosing Regimens of NER1006 versus 2L Polyethylene Glycol With Ascorbate: Post hoc Analysis of a Phase 3 Trial: 2017 Presidential Poster Award

The American Journal of Gastroenterology ◽

10.14309/00000434-201710001-00525 ◽

2017 ◽

Vol 112 ◽

pp. S276

Author(s):

Bharat Amlani ◽

Raf Bisschops

Keyword(s):

Polyethylene Glycol ◽

Bowel Preparation ◽

Phase 3 ◽

Post Hoc Analysis ◽

Poster Award ◽

Dosing Regimens ◽

Split Dosing ◽

Download Full-text

Achieving Successful Bowel Preparation (BBPS Score 2-3 per Segment) With Evening/Morning Split-Dosing Regimens of NER1006 versus Trisulfate: Post hoc Analysis of a Phase 3 Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-201710001-00522 ◽

2017 ◽

Vol 112 ◽

pp. S275

Author(s):

Michael Epstein ◽

Bharat Amlani ◽

Pradeep Bekal

Keyword(s):

Bowel Preparation ◽

Phase 3 ◽

Post Hoc Analysis ◽

Dosing Regimens ◽

Split Dosing ◽

Download Full-text

ACHIEVING ADEQUATE LEVEL BOWEL PREPARATION WITH EVENING/MORNING OR MORNING-ONLY SPLIT-DOSING REGIMENS OF NER1006 VERSUS STANDARD 2L PEG WITH ASCORBATE: POST HOC ANALYSIS OF A PHASE 3 TRIAL

10.26226/morressier.59a6b342d462b80290b541e9 ◽

2017 ◽

Author(s):

Raf Bisschops

Keyword(s):

Bowel Preparation ◽

Phase 3 ◽

Post Hoc Analysis ◽

Adequate Level ◽

Dosing Regimens ◽

Split Dosing ◽

Download Full-text

A double-blind, randomized, placebo-controlled phase 3 study to assess the efficacy and safety of relacorilant, a selective glucocorticoid receptor modulator, in patients with hypercortisolism due to cortisol-secreting adrenal adenoma(s)/hyperplasia

Endocrine Abstracts ◽

10.1530/endoabs.70.aep17 ◽

2020 ◽

Author(s):

Iacopo Chiodini ◽

Andreas Grauer ◽

Andreas Moraitis ◽

Massimo Terzolo

Keyword(s):

Glucocorticoid Receptor ◽

Adrenal Adenoma ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Receptor Modulator

Download Full-text

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.25 ◽

2019 ◽

Vol 3 ◽

pp. S25

Author(s):

Benjamin Ehst ◽

George Han ◽

Scott Guenthner ◽

Kimberly Eads ◽

Abby Jacobson

Keyword(s):

Disease Duration ◽

Efficacy And Safety ◽

Phase 3 ◽

Two Phase ◽

Abstract not available.

Download Full-text

The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.48 ◽

2017 ◽

Vol 1 ◽

pp. s49

Author(s):

Linda Stein Gold ◽

Sunil Dhawan ◽

Jonathan Weiss ◽

Zoe D Draelos ◽

Herman Ellman

Keyword(s):

Acne Vulgaris ◽

Pooled Analysis ◽

Phase 2 ◽

Efficacy And Safety ◽

Abstract Not Available

Download Full-text

Efficacy and safety outcomes in patients with probable or proven versus possible invasive mould disease from the phase 3 secure study, evaluating isavuconazole versus voriconazole for the primary treatment of invasive fungal disease caused by Aspergillus spp. or other filamentous fungi

10.26226/morressier.56d5ba24d462b80296c949e9 ◽

2016 ◽

Author(s):

Johan Maertens

Keyword(s):

Filamentous Fungi ◽

Invasive Fungal Disease ◽

Primary Treatment ◽

Fungal Disease ◽

Efficacy And Safety ◽

Phase 3 ◽

Safety Outcomes

Download Full-text